diabetes mellitus
In conclusion, GLP-1 treatment may        be considered in patients with diabetes mellitus secondary to chronic       pancreatitis, provided that a certain amount of alpha- and beta-cell secretory       capacity is still present.
In conclusion, GLP-1 treatment may        be considered in  @OBJECT$   @PREDICAT$   @SUBJECT$  secondary to chronic       pancreatitis, provided that a certain amount of alpha- and beta-cell secretory       capacity is still present.